Octreotide 24‐h prophylaxis in patients at high risk for post‐ERCP pancreatitis: results of a multicenter, randomized, controlled trial
Open Access
- 9 July 2001
- journal article
- clinical trial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 15 (7) , 965-972
- https://doi.org/10.1046/j.1365-2036.2001.01015.x
Abstract
Background: Pharmacological prophylaxis of post‐ERCP pancreatitis is costly and not useful in most non‐selected patients, in whom the incidence of pancreatitis is 5% or less. However, it could be us...Keywords
This publication has 31 references indexed in Scilit:
- Evaluation of post-ERCP pancreatitis: potential causes noted during controlled study of differing contrast mediaGastrointestinal Endoscopy, 1997
- Pancreatic Sphincter Hypertension Increases the Risk of Post-ERCP PancreatitisEndoscopy, 1997
- Effect of octreotide on sphincter of oddi motility in patients with acute recurrent pancreatitisDigestive Diseases and Sciences, 1996
- Use of corticosteroids in the prevention of post-ERCP pancreatitisGastrointestinal Endoscopy, 1995
- The Use of a Long-Acting Somatostatin Analogue (Octreotide) for Prophylaxis of Acute Pancreatitis after Endoscopic SphincterotomyEndoscopy, 1994
- Post-ERCP pancreatitis: Randomized, prospective study comparing a low- and high-osmolality contrast agentGastrointestinal Endoscopy, 1994
- Effect of somatostatin analog octreotide on human sphincter of OddiDigestive Diseases and Sciences, 1992
- Effect of Octreotide, a Long-Acting Somatostatin Analogue, on Plasma Amino Acid Uptake by the PancreasPancreas, 1991
- Endoscopic sphincterotomy complications and their management: an attempt at consensusGastrointestinal Endoscopy, 1991
- Dysmotility Disturbances of the Biliary Tract: Classification, Diagnosis, and TreatmentSeminars in Liver Disease, 1987